In June 2025, Greg Samios was appointed as the CEO of Wolters Kluwer Health. The division is a leading global provider of trusted clinical technology, research, life-long learning, and evidence-based solutions that drive effective decision-making and outcomes across healthcare.
A seasoned healthcare executive with more than twenty-five years of experience, Samios led the division’s two largest business units, Clinical Effectiveness and Health Learning, Research, and Practice. Samios has driven growth in Wolters Kluwer’s leading clinical decision support and clinical drug information products, UpToDate and Medi-Span. He also led the introduction of generative AI into the company’s healthcare products and solidified partnerships with leading digital health companies.
In a prior role at Wolters Kluwer, Samios headed the Legal & Regulatory U.S. business. His career experience before joining Wolters Kluwer included several health-focused positions at Elsevier spanning more than ten years. He earned an MBA from Duke University Fuqua School of Business and graduated with a B.S. and M.S. in Engineering from the University of Rochester. He serves as a Governing Board member of the American Chemical Society, one of the world’s largest scientific societies, and has been an advisor and mentor to several early-stage health information businesses.
LinkedIn